Cargando…
Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin
• All-trans retinoic acid (ATRA) and retinol significantly reduced ALDH1+ve cell subsets. • Co-treatment of ATRA or retinol with cisplatin significantly inhibited NSCLC cell survival. • Retinoic acid pathway inhibition induced apoptosis of chemo-resistant cells. • RAR and RXR nuclear receptors were...
Autores principales: | MacDonagh, Lauren, Santiago, Rhyla Mae, Gray, Steven G., Breen, Eamon, Cuffe, Sinead, Finn, Stephen P., O'Byrne, Kenneth J., Barr, Martin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868629/ https://www.ncbi.nlm.nih.gov/pubmed/33550205 http://dx.doi.org/10.1016/j.tranon.2021.101025 |
Ejemplares similares
-
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
por: MacDonagh, Lauren, et al.
Publicado: (2017) -
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer
por: MacDonagh, Lauren, et al.
Publicado: (2021) -
Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines
por: Heavey, Susan, et al.
Publicado: (2018) -
Linking ALDH1 and retinoic acid signaling
por: Markham, Nicholas O., et al.
Publicado: (2019) -
Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid
por: Casey, Nicholas P, et al.
Publicado: (2012)